Related Experiment Video
Updated: Aug 3, 2026
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Innovative treatments for pancreatic cancer
S M Lieberman1, H Hörig, H L Kaufman
1Department of Surgery, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
Pancreatic cancer is the fifth leading cause of cancer deaths in the United States with little or no impact from conventional treatment options. Significant advances in understanding basic immunology have renewed interest in using immunotherapy to treat pancreatic cancer. Cancer immunotherapy, including humanized MAbs, cytokines, and potent vaccine strategies, has been successful in animal models and is being evaluated in clinical trials. Gene therapy is also being explored using methods to inactivate oncogenes, replace defective tumor suppressor genes, confer enhanced chemosensitivity to tumor cells, and increase immunogenicity of tumor cells. Angiogenesis, an essential step in the growth and metastasis of pancreatic cancer, has been targeted by many antiangiogenic agents. Several clinical trials have been initiated to evaluate the role of these innovative strategies in patients with pancreatic cancer with increasingly sophisticated correlative studies to learn more about the mechanisms of tumor rejection with these agents. The rapid translation of basic science discoveries to clinical trials should result in the development of new effective treatments for patients with pancreatic cancer.
Insights
Pancreatic cancer treatments are limited. Novel approaches like immunotherapy, gene therapy, and antiangiogenic agents show promise in clinical trials for this deadly disease.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
- Cancer Metastasis
Background:
- Pancreatic cancer is a leading cause of cancer mortality in the U.S.
- Conventional treatments offer limited efficacy for pancreatic cancer.
- Advances in immunology have spurred interest in novel therapeutic strategies.
Purpose of the Study:
- To review innovative treatment strategies for pancreatic cancer.
- To highlight the potential of immunotherapy, gene therapy, and antiangiogenic agents.
- To discuss the translation of basic science discoveries into clinical applications.
Main Methods:
- Review of current research and clinical trials in pancreatic cancer.
- Exploration of immunotherapeutic approaches (e.g., monoclonal antibodies, vaccines).
- Evaluation of gene therapy techniques and antiangiogenic strategies.
Main Results:
- Immunotherapy, gene therapy, and antiangiogenic agents are under active investigation.
- These novel strategies have shown success in preclinical models and are being tested in human trials.
- Correlative studies are crucial for understanding treatment mechanisms.
Conclusions:
- Innovative treatments offer new hope for pancreatic cancer patients.
- Translating basic science into clinical practice is key to developing effective therapies.
- Further research and clinical trials are essential for advancing pancreatic cancer care.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: